eScholarshipmetadata only
PTH treatment is effective in the Aga2/+ mouse model of moderate to severe osteogenesis imperfecta
32 biomedical and clinical sciences (for-2020), 3202 clinical sciences (for-2020), orphan drug (rcdc), pediatric research initiative (rcdc), osteogenesis imperfecta (rcdc), rare diseases (rcdc), genetics (rcdc), congenital structural anomalies (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 922240
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.